Hologic, Inc. (HOLX) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$76.01
Price Target
$79.00
Target Range
$79.00 — $79.00
Analyst Rating
Hold
Forward P/E17.2x
Trailing P/E30.5x
Forward PEG—
Implied Growth+83.4%
Median Target$79.00
Analyst Spread0.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$79
+3.9%
Consensus
$79
+3.9%
Bull Case
$79
+3.9%
HOLX Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Hologic, Inc. (HOLX) has a Wall Street consensus price target of $79.00, based on estimates from 42 covering analysts. With the stock currently trading at $76.01, this represents a potential upside of +3.9%. The company has a market capitalization of $16.97B.
Analyst price targets range from a low of $79.00 to a high of $79.00, representing a 0% spread in expectations. The median target of $79.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 18 analysts rating the stock as a Buy or Strong Buy,23 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, HOLX trades at a trailing P/E of 30.5x and forward P/E of 17.2x. Analysts expect EPS to grow +83.4% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+24.6%
Avg Forward P/E87.0x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 BDXBecton, Dickinson and Company | $52.4B | $144.76 | $172.85 | +19.4% | Buy | 11.6x | 33 |
 BAXBaxter International Inc. | $8.8B | $16.98 | $19.75 | +16.3% | Hold | 8.9x | 36 |
 IDXXIDEXX Laboratories, Inc. | $46.1B | $579.23 | $773.13 | +33.5% | Buy | 39.9x | 22 |
 DXCMDexCom, Inc. | $23.3B | $60.36 | $80.88 | +34.0% | Buy | 24.2x | 52 |
 ISRGIntuitive Surgical, Inc. | $160.4B | $451.73 | $622.60 | +37.8% | Buy | 43.7x | 55 |
 MASIMasimo Corporation | $9.3B | $178.49 | $187.50 | +5.1% | Buy | 32.5x | 23 |
 GHGuardant Health, Inc. | $11.5B | $92.25 | $133.14 | +44.3% | Buy | — | 30 |
 EXASExact Sciences Corporation | $20.0B | $104.91 | $103.18 | -1.6% | Buy | 582.8x | 41 |
 QGENQiagen N.V. | $7.1B | $34.46 | $47.50 | +37.8% | Hold | 13.8x | 29 |
 NEOGNeogen Corporation | $2.0B | $9.18 | $11.00 | +19.8% | Hold | 25.7x | 11 |
Upside Potential Comparison
GHQGENISRGDXCMIDXXNEOGBDXBAXFull HOLX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See HOLX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HOLX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HOLX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHOLX — Frequently Asked Questions
Quick answers to the most common questions about buying HOLX stock.
What is the HOLX stock price target for 2026?
The consensus price target for HOLX is $79, close to the current price of $76.01 (3.9% implied move). Based on 42 analyst estimates, the stock appears fairly valued near current levels.
Is HOLX a buy, sell, or hold?
HOLX has a consensus rating of "Hold" based on 42 Wall Street analysts. The rating breakdown is mixed, with 23 Hold ratings making up the largest segment. The consensus 12-month price target of $79 implies 3.9% upside from current levels.
Is HOLX stock overvalued or undervalued?
With a forward P/E of 17.214x, HOLX trades at a relatively low valuation. The consensus target of $79 implies 3.9% appreciation, suggesting the market may be pricing in risks.
How high can HOLX stock go?
The most bullish Wall Street analyst has a price target of $79 for HOLX, while the most conservative target is $79. The consensus of $79 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover HOLX stock?
HOLX is heavily covered by Wall Street, with 42 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 18 have Buy ratings, 23 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the HOLX stock forecast?
The 12-month HOLX stock forecast based on 42 Wall Street analysts shows a consensus price target of $79, with estimates ranging from $79 (bear case) to $79 (bull case). The median consensus rating is "Hold".
What is HOLX's forward P/E ratio?
HOLX trades at a forward P/E ratio of 17.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 30.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy HOLX stock?
HOLX appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $79 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do HOLX price targets vary so much?
HOLX analyst price targets range from $79 to $79, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $79 consensus represents the middle ground.